5C1A — Esperite NV Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Esperite NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.51 | -5 | -7.21 | -8.54 | -12.9 |
| Depreciation | |||||
| Non-Cash Items | 0.859 | 1.13 | -0.325 | 0.635 | 5.66 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0 | -2.08 | 4.66 | 5.86 | 0.926 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.156 | -3.07 | -0.181 | 0.904 | -3.52 |
| Capital Expenditures | -0.647 | -1.77 | -2.34 | -1.46 | -0.791 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.5 | 0.077 | 0.024 | 0.076 | 0.019 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 1.85 | -1.7 | -2.32 | -1.39 | -0.772 |
| Financing Cash Flow Items | 0 | -1.45 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.492 | -1.66 | 1.79 | -0.067 | 4.55 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.48 | -6.46 | -0.648 | -0.54 | 0.308 |